Prospective surveillance of hospitalisations associated with varicella in New Zealand children
Authors: Authors: Wen SC et al.
Summary: Data from the New Zealand Paediatric Surveillance Unit (NZPSU) were analysed for this
investigation into the hospitalisation burden of varicella. Cases (0–14 years) were defined as varicella and
post-varicella complications requiring hospitalisation, including stroke syndromes where varicella occurred in
the preceding 6 months, reported to the NZPSU between 1 November 2011 and 31 October 2013. Of a total of
178 notifications, 144 were confirmed cases. The hospitalisation rate was 8.3/100,000 children per year, with
over-representation among Māori and Pacific Island (PI) children, who accounted for 74% of hospitalisations
and both had significantly higher incidence rate ratios (2.8 and 3.9, respectively) compared with European
children (p<0.01). Complications included infection (75%), respiratory (11%), neurological (11%), electrolyte
disturbance (6%) and haemorrhagic varicella (4%). Nine percent were immunocompromised. Median duration
of hospital admission was 4 days, with 9% requiring intensive care admission. There were no reported deaths;
however, 19% had ongoing problems at discharge.
Reference: Reference: J Paediatr Child Health. 2015;51(11):1078-83
Abstract
Trends in ethnic and socioeconomic inequalities in cancer survival, New Zealand, 1991–2004
Authors: Soeberga M et al.
Summary: Summary: These researchers assessed trends in cancer survival inequalities in New Zealand by ethnic and
income group, in a cohort of 126,477 people diagnosed with cancer between 1991 and 2004 and followed
to 2006. The analysis measured inequalities pooled over time with excess mortality rate ratios (EMRRs) and
changes over time in those inequalities by using EMRRs, excess mortality rate differences (EMRDs) and absolute
differences in relative survival risks (RSRDs); all three were estimated by cancer-site and (for EMRRs only)
pooled across all sites. Pooled over time and all sites, Māori had an EMRR of 1.29 (95% CI, 1.24 to 1.34)
compared to non-Māori. The low- compared to high-income EMRR was 1.12 (95% CI, 1.09 to 1.15). Pooled
over cancers, there was no change in the ethnic EMRR over time but the income EMRR increased by 9% per
decade (1–17%). Changes over time in site-specific inequalities were imprecisely measured, but the direction
of change was usually consistent across EMRRs, EMRDs and RSRDs. Ethnic inequalities in cancer survival
persisted over time, with slower improvements for low-income people.
Reference: Reference: Cancer Epidemiol. 2015;39(6):860-2
Abstract
Patterns of axillary lymph node metastases and recurrent disease in grade 1 breast cancer in a New Zealand cohort: Does ethnicity matter?
Authors: Meredith I et al.
Summary: Summary: Using data from the Auckland Breast Cancer Registry (ABCR) and the Waikato Breast Cancer
Registry (WBCR), these researchers identified 2857 women newly diagnosed with grade 1 primary invasive
breast cancer between 1 June 2000 and 31 May 2013. Almost one-fifth (19.0%) had axillary lymph node
involvement, and recurrent disease (locoregional or distant) developed in 5.1%. Pacific and Māori women were
more likely than NZ European women to have larger tumours and lymphovascular invasion (LVI). Predictors
for axillary node involvement were tumour size >10 mm, LVI and non-screen detected cancers. Factors found
to predict recurrent and/or metastatic disease were tumour size >10 mm, lobular carcinoma and breastconserving
surgery without radiotherapy. Ethnicity did not independently predict axillary nodal involvement,
recurrent and/or metastatic disease, or breast cancer-specific mortality in this patient population.
Reference: Reference: Cancer Epidemiol. 2015;39(6):994-9
Abstract